期刊文献+

调强适形放射治疗与常规放疗联合化疗治疗局部晚期鼻咽癌的临床疗效分析 被引量:7

Intensity modulated conformal radiation therapy and clinical efficacy of conventional radiotherapy combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma
暂未订购
导出
摘要 目的:探讨调强适形放射治疗联合化疗(IMRT+CT)与常规放疗联合化疗(RT+CT)治疗局部晚期鼻咽癌的临床效果。方法:将128例经局部晚期鼻咽癌患者患者,随机分为两组,对照组采用常规RT+CT方案治疗,观察组采用IMRT+CT方案治疗,用Kaplan-Meier法分析患者1和2年局部区域控制率、无远处转移生存率和总生存率。结果:对照组1年和2年局部区域控制率、无远处转移生存率、总生存率分别为89.1%、90.6%、89.1%和79.7%、82.8%、79.7%,观察组为100.0%。98.4%、98.4%和98.4%、95.3%、98.4%,观察组2年的局部区域控制率和总生存率优于对照组(P<0.05)。结论:调强适形放射联合化疗治疗治疗局部晚期鼻咽癌患者的局部区域控制率和总生存率优于常规的放疗联合化疗,值得临床应用。 Objective To investigate the effect of intensity modulated conformal radiation therapy combined with chemotherapy(IMRT+CT) and conventional radiotherapy combined with chemotherapy(RT+CT) in the treatment of local advanced nasopharyngeal carcinoma(NPC).Methods 128 local advanced NPC patients were divided into observation group and control group randomly,which were treated by IMRT+CT and RT+CT respectively.One and two-year local control rates,distant metastasis-free survivals and overall survivals were analyzed by the method of Kaplan-Meier.Results The one and two-year local control rates,distant metastasis-free survivals and the overall survivals were 89.1%、90.6%、 89.1% and 79.7%、82.8%、79.7% in observation group,while 100.0%、98.4%、98.4% and 98.4%、95.3%、98.4% in control group.The twoyear local control rate and the overall survival in observation group were higher than those in control group(P0.05).Conclusion The two-year local control rate and overall survival in observation group was higher than those in control group in treating local advanced NPC patients which was worthy of clinical application.
出处 《吉林医学》 CAS 2012年第12期2470-2471,共2页 Jilin Medical Journal
关键词 调强适形放射治疗 放疗 化疗 晚期鼻咽癌 Intensity-modulated radiation therapy Radiotherapy Chemotherapy Advanced nasopharyngeal carcinoma
  • 相关文献

参考文献5

二级参考文献43

共引文献91

同被引文献57

  • 1金风,欧阳金陵,董红敏,吴伟莉,陈海霞,何志惠.鼻咽癌后程三维适形放疗加时间调节化疗的临床前瞻性随机研究[J].中华放射肿瘤学杂志,2005,14(4):269-272. 被引量:8
  • 2张支农,张剑,陈红云,游向荣,喻云助.中西医结合治疗晚期鼻咽癌46例总结[J].湖南中医杂志,2006,22(1):1-2. 被引量:7
  • 3侯良宝,张建军,刘彦中.放疗联合化疗治疗局部晚期鼻咽癌的疗效观察[J].中国医师进修杂志,2006,29(1):15-17. 被引量:6
  • 4Bonner JA,Harari PM,Gimlt J,eta1.Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck[J].NEngl J Med.2013,35(4):567-578.
  • 5Vermorken JB,Mesia R.Platinumbased chemotherapy plus cetuximab in head and neckcancer[J].NEngl J Med,2013,359(11):1116-1127.
  • 6Milas L,Mason KA,Ang KK.Epidermal growthfactor receptor and its inhibition in radiotherapy:invivo ndings[J].Int J Radiat Biol,2013,79(7):539-545.
  • 7Devaraj S, Valleggi S, Siegel D, et al. Role of C - reactive protein in contributing to increased cardiovascular risk in metabolic syndrome [ J ]. Curr Atheroscler Rep,2010 (12) : 110 - 118.
  • 8Verbakel WF, Cuijpers JP, Hoffmans D, et al. Volumetric intensity - modulated arc therapy vs. conventional IMRT in head - and - neck cancer:a comparative planning and dosimetric study [ J ]. Int J Radiat Oncol Biol Phys, 2009, 74 (1) :252 -259.
  • 9Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications[ J]. Rev Endocr Metab Disord,2010,11 (1) :61 -74.
  • 10Diaz Miqueli A, Rolff J, Lemm M,et ai. Radiosensitisation of U87MG brain tumours by anti - epidermal growth factor receptor monoclonal antibodies [J]. Br J Cancer,2009,100(6) :950 -958.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部